Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Search
  1. OncologyPRO
  2. Meeting resources
  3. ESMO 2016

Introduction and first vote

Date

08 Oct 2016

Session

Should every metastatic prostate cancer patient get germline testing?

Presenters

Rob Bristow

Authors

R. Bristow

Author affiliations

  • Radiation Medicine Program, Princess Margaret Cancer Centre, M5G2M9 - Toronto, ON/CA
More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Yes

Presenter: Elena Castro Marcos

Session: Should every metastatic prostate cancer patient get germline testing?

Resources:

Presentation

Webcast

Second vote and conclusions

Presenter: Rob Bristow

Session: Should every metastatic prostate cancer patient get germline testing?

Resources:

Presentation

Webcast

No

Presenter: Bertrand Tombal

Session: Should every metastatic prostate cancer patient get germline testing?

Resources:

Presentation

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings